GENE ONLINE|News &
Opinion
Blog

2026-02-05|

Researchers Study Supersulfide Molecules Formed During Natto Fermentation and Their Potential Health Implications

by GOAI
Share To

Researchers at Osaka Metropolitan University, led by Professor Hideshi Ihara, have conducted a study examining the chemical properties of natto, a traditional Japanese dish made from fermented soybeans. The research focused on the production of supersulfide molecules during the fermentation process. These molecules have attracted interest in medical and nutritional sciences due to their potential health-related properties.

The study analyzed how these supersulfide compounds form during natto’s fermentation and explored their possible implications for human health. Supersulfides are known for their unique chemical structure and reactivity, which may contribute to various biological functions. The findings highlight the complex chemistry behind natto and its potential significance in both dietary and medical contexts. Researchers continue to investigate how these compounds could be utilized or understood further in relation to human health benefits.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 5, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Amrize Corporation Appoints Three New Directors Following Departure of James Carter and Linda Nguyen
2026-02-11
Xilio Therapeutics Prices Public Offering of 12 Million Shares at $3 Each
2026-02-11
Study Maps Cellular and Molecular Changes in Pancreatic Tissue During Type 1 Diabetes Progression
2026-02-11
Applied Materials Resolves U.S. Export Control Investigation with Financial Penalty and Compliance Measures
2026-02-11
Sands China Partners with Alipay and Macau Pass to Expand Cashless Payment Systems in Macau
2026-02-11
Society Pass Incorporated Prices Public Offering at $3.00 Per Share to Raise $3 Million
2026-02-11
Beach Cities Commercial Bank Reports $12.4 Million Q4 Net Income with $2.1 Billion in Total Assets
2026-02-11
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
Scroll to Top